factor V Leiden mutation

A mutation in the gene for the blood clotting factor V that leads to a type of increased clotting tendency known as activated protein C resistance (APC resistance). The mutation involves a CpG dinucleotide, a common location for a mutation. APC resistance from this cause is recognized as a cause of stroke in children but the mutation is often detected for the first time in people over 60 suffering a first episode of thrombosis. The mutation was discovered in the Thrombosis and Haemostasis Research Centre, University Hospital, Leiden, Netherlands.

Collins Dictionary of Medicine © Robert M. Youngson 2004, 2005

References in periodicals archive

Patients with Factor V Leiden mutation requiring anticoagulation with warfarin should receive extensive counseling regarding alcohol use and the risk of re-initiating therapy after self-discontinuation without heparin bridging.

A 52-year-old man with ecchymotic leg ulcers

[41] found APC resistance in 4 (11%) of 35 patients, but the factor V Leiden mutation was confirmed in only 1 of these 4 cases (3%).

Association between thrombophilia and the post-thrombotic syndrome

Factor V Leiden mutation and the risk for thromboembolic disease: a clinical perspective.

Combined heterozygote factor V Leiden mutation and anticardiolipin antibody positivity in a young patient with spontaneous deep vein thrombosis/Kombine heterozigot faktor V Leiden mutasyonu ve antikardiyolipin antikor pozitifligi olan genc bir hastada derin ven trombozu

Activated protein C resistance, the factor V Leiden mutation, and a laboratory testing algorithm.

Factor V Leiden: an overview

Detection of factor V Leiden mutation in severe pre-eclamptic Hungarian women.

Bases geneticas y moleculares de la preeclampsia

Factor V Leiden mutation Protein C and S deficiency are the leading causes of thrombophilia with strong association of Factor V Leiden as a risk for developing DVT and CVA.

High prevalence of protein C protein S antithrombin deficiency and Factor V Leiden mutation as a cause of hereditary thrombophilia in patients of venous thromboembolism and cerebrovascular accident

Hemiplegic cerebral palsy and factor V Leiden mutation. J Med Genet.

Fetal thrombophilia, perinatal stroke, and novel ideas about CP: recent research findings point to thrombophilia and to stroke before or right after birth as one more basis for cerebral palsy. But can the knowledge make a difference in outcome?

Detection of the factor V Leiden mutation by a modified photocross-linking oligonucleotide hybridization assay.

Genotype-specific signal generation based on digestion of 3-way DNA junctions: application to KRAS variation detection

Doing nothing is perilous in a woman of childbearing age carrying the factor V Leiden mutation because pregnancy is also a risk factor for VTE in these women, Dr.

Estrogen use with factor V Leiden not advised

A positive test result for activated protein C resistance typically warrants a polymerase chain reaction assay to distinguish the factor V Leiden mutation from other causes of activated protein C resistance.

Evaluating idiopathic venous thromboembolism: what is necessary, what is not

The factor V Leiden mutation is present in 3% to 5% of the general white population in heterozygous form.

Activated protein C resistance, the factor V Leiden mutation, and a laboratory testing algorithm. (Original Articles)

(4-6) Women with familial coagulation disorders, including factor V Leiden mutation, prothrombin G20210A mutation, deficiencies of anticoagulant proteins (antithrombin, protein C, protein S), and elevations in procoagulant factors (factor VIII, factor IX, factor XI), are 2 to 8 times more likely to experience a VTE event than are unaffected individuals.

Combination hormonal contraception and venous thromboembolism risk